In a previous work, the CCL5 overexpression observed starting from the early stage of demyelinating disorder was proposed to account for the altered glutamate exocytosis detected in cortical and spinal cord glutamate nerve endings of EAE mice [9]. Here, CCL5 is linked to demyelinating disease.